HeroesFIRST 2024 Nationwide Voting Launch
Nationwide Voting Launches for ImageFIRST’s 4th Annual HeroesFIRST Contest
September 18, 2024 12:30 ET | ImageFIRST Healthcare Laundry Specialists
King of Prussia, PA, Sept. 18, 2024 (GLOBE NEWSWIRE) -- ImageFIRST® proudly announces the launch of nationwide voting for its 4th Annual HeroesFIRST Contest, celebrating exceptional healthcare...
corza-big100
Corza Medical Named to the 2024 MedTech Big 100 List
September 18, 2024 08:55 ET | Corza Medical Inc.
Corza Medical, a leading global medical technology company committed to remarkable service, trusted performance, and outstanding value named to BIG100!
Foto Logo Blank.png
Free Zones and Human Capital: The Dominican Republic’s Formula for Leading nearshoring in the Region
September 12, 2024 20:10 ET | MICM
The Dominican Republic is no longer just a well-kept secret for vacationers; it is emerging as a hub for nearshoring and industrial growth.
U.S. Health & Wellness Spa Market
U.S. Health & Wellness Spa Market Focused Insights 2024-2029, with Exclusive Data on 33 Key Vendors
September 10, 2024 07:42 ET | Research and Markets
Dublin, Sept. 10, 2024 (GLOBE NEWSWIRE) -- The "U.S. Health & Wellness Spa Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering.The U.S. Health &...
Polaris Logo - v2.png
Medical Tourism Market is Projected to be US$ 80.07 Billion by 2032, at a CAGR of 24.7% from 2024 to 2032 | Polaris Market Research (PMR)
September 09, 2024 08:31 ET | Polaris Market Research & Consulting LLP
New York, USA, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Market Overview: The global medical tourism market size was valued at USD 11.20 billion in 2023. The market is anticipated to reach USD 80.07...
lumos.png
Lumos Pharma Announces Abstract Accepted for Presentation at September Medical Meeting, SLEP 2024
September 05, 2024 09:00 ET | Lumos Pharma, Inc.
AUSTIN, Texas, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical stage biopharmaceutical company focused on therapeutics for rare diseases, announced today that an...
XWELL_Black_CMYK.jpg
XWELL Appoints Ezra Ernst as New President and Chief Executive Officer
September 05, 2024 08:00 ET | XWELL, Inc.
NEW YORK, Sept. 05, 2024 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) (“XWELL” or the “Company”), an authority in wellness solutions for people on the go, today announced the appoint of Ezra T....
Lifecore-Corporate_Logo_2C.png
Lifecore Biomedical Announces Chief Financial Officer Transition
August 29, 2024 07:00 ET | Lifecore Biomedical, Inc.
CHASKA, Minn., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization...
FSR Scientific Advisory Board Members
Foundation for Sarcoidosis Research Expands Scientific Advisory Board with 14 New Experts to Enhance Sarcoidosis Research and Patient Care
August 28, 2024 16:48 ET | Foundation for Sarcoidosis Research
Foundation for Sarcoidosis Research appoints fourteen new members to serve the organization’s Scientific Advisory Board.
XWELL_Black_CMYK.jpg
XWELL Announces Partnership with Priority Pass
August 26, 2024 16:15 ET | XWELL, Inc.
NEW YORK, Aug. 26, 2024 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) (“XWELL” or the “Company”), an authority in wellness solutions for people on the go, today announced a two-year partnership...